Denali Therapeutics Inc. (MUN:4DN)
Germany
· Delayed Price · Currency is EUR 19.54
+0.45 (2.33%)
At close: Feb 3, 2026
Denali Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -512.54 | -422.77 | -145.22 | -325.99 | -290.58 | Upgrade
|
| Depreciation & Amortization | 14.81 | 8.99 | 8.83 | 10.38 | 8.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -14.54 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 7.9 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -10.25 | -35.12 | -43.95 | -1.64 | 8.75 | Upgrade
|
| Stock-Based Compensation | 99.63 | 102.88 | 108.1 | 99.85 | 85.25 | Upgrade
|
| Other Operating Activities | -4.4 | -4.07 | -3.72 | -3.29 | -2.98 | Upgrade
|
| Change in Accounts Payable | -7.52 | 1.44 | 2.43 | 2.27 | 3.71 | Upgrade
|
| Change in Unearned Revenue | - | - | -290.53 | -34.46 | -15.66 | Upgrade
|
| Change in Other Net Operating Assets | 7.67 | 15.5 | -1.83 | 8.16 | -8.46 | Upgrade
|
| Operating Cash Flow | -412.6 | -347.69 | -357.99 | -244.72 | -211.39 | Upgrade
|
| Capital Expenditures | -9.5 | -15.91 | -12.94 | -17.83 | -8.5 | Upgrade
|
| Investment in Securities | 264.78 | -72.84 | 262.25 | -123.55 | -13.13 | Upgrade
|
| Investing Cash Flow | 255.28 | -88.76 | 249.31 | -141.39 | -21.63 | Upgrade
|
| Long-Term Debt Repaid | -8.17 | -32.34 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -8.17 | -32.34 | - | - | - | Upgrade
|
| Issuance of Common Stock | 925.71 | 517.12 | 17.82 | 311.73 | 19.35 | Upgrade
|
| Other Financing Activities | -728.32 | -0.48 | - | -1.06 | - | Upgrade
|
| Financing Cash Flow | 189.22 | 484.3 | 17.82 | 310.67 | 19.35 | Upgrade
|
| Net Cash Flow | 31.9 | 47.85 | -90.86 | -75.43 | -213.67 | Upgrade
|
| Free Cash Flow | -422.1 | -363.61 | -370.93 | -262.55 | -219.89 | Upgrade
|
| Free Cash Flow Margin | - | - | -112.22% | -242.06% | -451.88% | Upgrade
|
| Free Cash Flow Per Share | -2.44 | -2.21 | -2.70 | -2.09 | -1.81 | Upgrade
|
| Cash Interest Paid | 0.72 | 0.3 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.05 | - | 0 | 0.05 | 0.21 | Upgrade
|
| Levered Free Cash Flow | -244.19 | -200.74 | -298.35 | -141.03 | 200.41 | Upgrade
|
| Unlevered Free Cash Flow | -244.19 | -200.74 | -298.35 | -141.03 | 200.41 | Upgrade
|
| Change in Working Capital | 0.15 | 16.94 | -289.93 | -24.03 | -20.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.